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Abstract
Dopamine is central to a number of cognitive functions and brain disorders. Given the cost of neurochemical imaging in humans,
behavioural proxy measures of dopamine have gained in popularity in the past decade, such as spontaneous eye blink rate
(sEBR). Increased sEBR is commonly associated with increased dopamine function based on pharmacological evidence and
patient studies. Yet, this hypothesis has not been validated using in vivo measures of dopamine function in humans. To fill this
gap, we measured sEBR and striatal dopamine synthesis capacity using [18F]DOPA PET in 20 participants (nine healthy individu-
als and 11 pathological gamblers). Our results, based on frequentist and Bayesian statistics, as well as region-of-interest and
voxel-wise analyses, argue against a positive relationship between sEBR and striatal dopamine synthesis capacity. They show
that, if anything, the evidence is in favour of a negative relationship. These results, which complement findings from a recent
study that failed to observe a relationship between sEBR and dopamine D2 receptor availability, suggest that caution and nuance
are warranted when interpreting sEBR in terms of a proxy measure of striatal dopamine.
Introduction
Dopamine is a key ascending neuromodulator subserving a range of
cognitive functions, including motivation, learning and attention. In
turn, striatal dopamine dysregulation is a common feature across
many psychiatric disorders in which those functions are impaired,
including addiction, schizophrenia, attention deﬁcit hyperactivity dis-
order and depression (Russo & Nestler, 2013; Nutt et al., 2015;
Grace, 2016). Unfortunately, direct assessment of dopamine function
in humans is only possible with expensive and invasive techniques
such as positron emission tomography (PET), which require com-
plex infrastructure and in-depth methodological expertise. As a
consequence, non-invasive proxy measures have gained in popular-
ity. In particular, spontaneous eye blink rate (sEBR) has been used
in many studies to investigate dopamine’s role in various cognitive
tasks and patient populations (for a comprehensive review see Jong-
kees & Colzato, 2016).
Evidence supporting a link between dopamine function and sEBR
comes primarily from pharmacological studies in both humans and
animals. These studies have shown that dopamine-enhancing drugs
generally increase sEBR (Karson, 1983; Strakowski et al., 1996),
whereas dopamine-decreasing drugs tend to decrease sEBR (Lawr-
ence & Redmond, 1991; Mavridis et al., 1991) – although a number
of other studies have reported null or opposite results (Ebert et al.,
1996; Kleven & Koek, 1996; van der Post et al., 2004; Mohr et al.,
2005; Kotani et al., 2016). Similarly, brain disorders characterized
by a hypo-dopaminergic state, such as Parkinson’s disease, have
been mostly associated with decreased sEBR (Deuschl & Godde-
meier, 1998; Chen et al., 2003), whereas disorders characterized by
a hyperdopaminergic state, such as schizophrenia, have been associ-
ated with increased sEBR (Chen et al., 1996; Chan et al., 2010).
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These observations have led to the pervasive hypothesis that sEBR
is positively correlated with dopamine function (Jongkees & Col-
zato, 2016).
However, establishing sEBR as a reliable marker of human dopa-
mine function requires direct evidence for a relationship between
sEBR and in vivo measures of dopamine function in humans. Dopa-
mine function can be measured in several ways, for example, in
terms of synthesis capacity, transporter density and/or (changes in)
receptor availability. Only two PET studies to date have tackled this
question, and both of these focused on dopamine receptor availabil-
ity. The ﬁrst study by Groman et al. (2014) measured dopamine D2
and D1 receptor availabilities in vervet monkeys, using [18F]fal-
lypride and [11C]NNC-112 PET, respectively. The results showed
that striatal dopamine D2 (but not D1) receptor availability was pos-
itively correlated with sEBR, as well as with D2 receptor agonist-
induced changes in sEBR. However, a recent study by Dang et al.
(2017) was unable to replicate these results in humans. Using [18F]-
fallypride PET and the dopamine D2 receptor agonist bromocriptine,
they found that dopamine D2 receptor availability was neither
related to baseline sEBR or bromocriptine-induced changes in
sEBR. In this study, we focused on another aspect of dopamine
function, namely striatal dopamine synthesis capacity, as measured
by [18F]DOPA PET. Based on the above-described literature and the
commonly assumed positive relationship between sEBR and dopa-
mine function (Jongkees & Colzato, 2016), we hypothesized that
dopamine synthesis capacity would be positively related to sEBR.
This hypothesis is further in line with a previous report showing that
sEBR is positively correlated with post-mortem measures of dopa-
mine concentration in the caudate nucleus of monkeys treated with
the neurotoxic drug MPTP (Taylor et al., 1999).
Materials and methods
Participants
Thirty male participants were recruited, among which were 15
pathological gamblers (PGs) and 15 matched healthy controls
(HCs). The PET data from these participants have been reported in
a previous study comparing baseline dopamine synthesis capacity
between groups (van Holst et al., 2017). PGs were recruited through
advertisement and addiction treatment centres and reported not to be
medicated or in treatment for their gambling at the time of the PET
study. HCs were recruited through advertisement. All gamblers qual-
iﬁed as PGs as they met ≥ 5 DSM-IV-TR criteria for pathological
gambling. Current drug use disorder was a reason for exclusion for
all participants. Additionally, participants were excluded if they were
currently following psychiatric treatment, drank more than four alco-
holic beverages daily, used marijuana more than once per month,
were using (psychotropic) medication, had a lifetime history (as
assessed with the MINI interview) of schizophrenia, bipolar
disorder, attention deﬁcit hyperactivity disorder, autism, bulimia,
anorexia, anxiety disorder, obsessive–compulsive disorder or had a
past 6-month history of major depressive episode.
Nine participants (three PGs; six HCs) were not included due to
technical problems with the electro-oculography (EOG) recordings
(data loss > 50% of the total recording time). Data loss was related
to EOG ampliﬁer saturation (output voltage of the ampliﬁer exceed-
ing its operating range sensitivity). Three participants were kept in
the analyses despite minor data loss (exploitable data: 3.5, 4.4 and
4.5 min). One gambler was further excluded because he met the
DSM-IV-TR criteria for past year marijuana dependence, which is
known to inﬂuence sEBR measures (Kowal et al., 2011). As a
result, the ﬁnal sample comprised 20 participants (mean age: 38.2,
age range: 22–54, gamblers: n = 11, controls: n = 9).
All participants provided written informed consent to take part in
the study, which was approved by the regional research ethics com-
mittee (Commissie Mensgebonden Onderzoek, region Arnhem-Nij-
megen, registration number NL41522.091.12).
Study procedures
The study took place at the Radboud University Medical Center.
Upon arrival of the participants, spontaneous eye blink rate (sEBR)
was measured using EOG recordings (see detailed description
below). Approximately 1 h before entering the PET scanner, partici-
pants received 150 mg of carbidopa and 400 mg of entacapone to
reduce peripheral metabolism of [18F]DOPA and increase tracer
availability in the brain while having no psychotropic side effects.
The participants further performed computerized tasks not reported
here.
Spontaneous eye blink rate: recording and analyses
We followed standard procedures for the acquisition, preprocessing
and analysis of the EOG data (Colzato et al., 2009; Slagter et al.,
2010). The data were acquired during the day (3:30–4:30 pm) over a
6-min period, using two vertical and two horizontal Ag-AgCl elec-
trodes placed around the left eye. The sampling rate was 100 Hz. The
vertical EOG signal (vEOG), used for eye blink assessment, was
obtained from a bipolar montage using the electrodes placed above
and below the eye. The horizontal EOG (hEOG) signal, used to
exclude artefacts produced by saccades, was obtained from a bipolar
montage using the electrodes placed lateral to the external canthi.
Participants were comfortably seated and instructed to ﬁxate the
wall in front of them while they believed the system was being cali-
brated and the experimenter was outside of the room. They were not
instructed in any way about blinking and were asked not to move
their head or activate their facial muscles to minimize EOG arte-
facts.
The vEOG signals were rectiﬁed and band-pass ﬁltered between
0.5 and 20 Hz. Eye blinks were detected using an automated proce-
dure based on a voltage change threshold of 100 lV in a time inter-
val of 400 ms. The vEOG signal was then visually inspected by
two of the authors (R.L. and G.S.) to assess detection accuracy (i.e.
presence/absence of blinks) and remove potential artefacts resulting
from muscle activity and saccades as detected in the hEOG signal.
As the inter-rater reliability was very high (Cronbach’s a = 0.989),
the resulting sEBR measures from the two raters were averaged for
subsequent analyses.
PET and MRI data acquisition
All PET scans were acquired at the department of Nuclear Medicine
of the Radboud University Medical Center using a Siemens mCT
PET/CT camera (with 40 slice CT, voxel size 4 9 4 mm in-plane,
5 mm slice thickness). Participants were positioned as comfortably
as possible, in a supine position, with the head slightly ﬁxated in a
headrest to avoid movement. First, a low-dose CT was made for
attenuation correction of the PET images, followed by an 89-min
dynamic PET scan. The scan started at the same time as the bolus
injection of the [18F]DOPA into an antecubital vein. Images were
reconstructed with an ordered subset expectation maximization algo-
rithm with weighted attenuation and time-of-ﬂight recovery, scatter
corrected and smoothed with a 4-mm FWHM kernel.
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A high-resolution anatomical scan (T1-weighted MP-RAGE,
TR = 2300 ms, TE = 3.03 ms, 8° ﬂip-angle, 192 sagittal slices,
slice-matrix size = 256 9 256, voxel size 1 9 1 9 1 mm3) was
obtained using a 3 Tesla MR Siemens scanner at the Donders Cen-
tre for Cognitive Neuroimaging and used for co-registration with the
PET data.
PET data preprocessing and analyses
We realigned the [18F]DOPA images to the middle (11th) frame to
correct for movement during scanning using SPM8 (http://www.fil.
ion.ucl.ac.uk/spm/). The mean [18F]DOPA image and the realigned
frames were coregistered to the structural MRI scan using SPM8.
Higher [18F]DOPA uptake, indexed by higher Ki values, is estab-
lished to reﬂect higher dopamine synthesis capacity (Snow et al.,
1993). To create Ki images representing the amount of tracer accu-
mulated in the brain relative to a cerebellar region of reference, we
used an in-house graphical analysis program implementing Patlak
plotting (Patlak & Blasberg, 1985). Ki images were generated from
PET frames corresponding to 24–89 min. These images are compa-
rable to Ki images obtained using a blood input function but are
scaled to the volume of tracer distribution in the reference region.
Finally, structural MRI scans were normalized to a standard MNI
template (IBASPM152), and the transformation matrix was applied
to coregistered Ki images. As expected from previous studies (Rak-
shi et al., 1999), the voxels with the highest Ki values were located
in the striatum and the brainstem (Fig. 1A).
For the main analyses, Ki values were extracted from an indepen-
dently and functionally deﬁned striatal region of interest, based on a
whole-brain [18F]DOPA PET template normalized to MNI space
(Garcıa-Gomez et al., 2013, downloaded from www.nitrc.org/projec
ts/spmtemplates). Speciﬁcally, we retained the template voxels in
which Ki values were at least three standard deviations above the
template mean, thus approximating the anatomical boundaries of the
striatum (in which [18F]DOPA binding is maximal, see Fig. 1A).
For the exploratory voxel-wise analysis (Fig. 2B), we performed
a linear regression using SPM8. The analysis was restricted to an
anatomical mask covering the entire striatum (Choi et al., 2012),
within which the results were corrected for multiple comparisons
using a voxel-wise family-wise error (FWE)-corrected threshold of
P < 0.05.
Statistics
As extracted Ki values were non-normally distributed (Kol-
mogorov–Smirnov test: P < 0.003), we used rank correlation coefﬁ-
cients (Spearman q). We also performed partial regression analyses,
in which beta coefﬁcients were estimated using bootstrapping in
SPSS. Bayesian analyses were conducted using JASP (Wagenmakers
et al., 2018).
Results
In contrast to our prediction, frequentist statistics indicated a nega-
tive relationship between sEBR and Ki values (Spearman
⍴ = 0.504, P = 0.024, Fig. 1B). As both age and gambling status
are known to be related to Ki values (Berry et al., 2016; van Holst
et al., 2017), we next regressed sEBR onto Ki values while adding
these two variables as covariates, revealing a marginally signiﬁcant
negative relationship between sEBR and dopamine synthesis capac-
ity (b = 1.82, P = 0.09).
Given the unexpectedness of this ﬁnding, we sought to quantify
the evidence for the null hypothesis that sEBR and Ki values are
not positively correlated (H0), as opposed to positively correlated
(H1). We used a Bayesian analysis with an uninformative (ﬂat) prior
distribution over the (0, 1) interval. The relative evidence in favour
of H0 over H1 was strong (Bayes factor: BF01 = 10.34), indicating
that our data are 10 times more likely under the null hypothesis of
no positive relationship than under the alternative hypothesis of a
positive relationship. Importantly, a Bayes factor robustness check
showed that this conclusion holds even when using strong prior
beliefs in the existence of a positive correlation (Fig. 2A). In fact,
there was also moderate evidence (BF10 = 4.90) in favour of a nega-
tive relationship between sEBR and Ki values (H1 vs. H0 deﬁned
as an absence of negative relationship).
Finally, an exploratory voxel-wise analysis showed that the nega-
tive relationship between sEBR and Ki values was strongest in the
left nucleus accumbens (Fig. 2B).
Control analyses
To assess the robustness of our results, we performed a number of
control analyses. First, we re-ran our analyses after excluding the
data from the three participants with incomplete sEBR datasets. The
Fig. 1. Main results: mapping of dopamine synthesis capacity and relationship with spontaneous eye blink rate in the striatum. (A) On the left, whole-brain map of mean
Ki values across the 20 participants included in the analyses. On the right, the striatal functional mask used for the region-of-interest analyses is depicted in red. (B) Negative
correlation between spontaneous eye blink rate and Ki values in the striatal mask (⍴ = 0.504, P = 0.024). The shaded area represents the 95% conﬁdence interval. Note
that the P-value of the negative correlation drops below signiﬁcance (⍴ = 0.417, P = 0.096) when removing the three most extreme Ki values (highest Ki value and two
lowest Ki values, respectively 2.1 and 2.4 standard deviations away from the mean). [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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results remained unchanged, showing a negative correlation between
sEBR and striatal dopamine syntheses (Spearman ⍴ = 0.5,
P = 0.016), while the Bayesian correlation analysis indicated moder-
ate to strong evidence against hypothesis H1 of a positive correla-
tion (BF01 = 9.95). When splitting the data as a function of
gambling status, we observed a negative association between sEBR
and Ki values in both groups [healthy controls (n = 9): ⍴ = 0.63,
P = 0.067; pathological gamblers (n = 11): ⍴ = 0.46, P = 0.15].
Although P-values did not reach signiﬁcance, Bayesian analyses
similarly revealed moderate evidence against a positive correlation
(healthy controls: BF01 = 5.66; pathological gamblers: BF01 = 6.29),
although, of course, these values should be interpreted with caution
given the small sample sizes of these subgroups.
Finally, we veriﬁed that our results were not inﬂuenced by the
method used to deﬁne eye blinks. Indeed, in our main analysis, we
used a relatively low detection threshold of 100 lV, which has the
advantage of capturing most blinks (high sensitivity), but has the
disadvantage of increasing the likelihood of false positives due to
muscular artefacts (decreased speciﬁcity), which then requires man-
ual (i.e. subjective) editing. To circumvent that issue, we re-ran our
analyses using more conservative thresholds (200 and 300 lV),
which provide increased speciﬁcity and thus eliminate the need for
manual editing (at the cost of decreased sensitivity). The resulting
sEBR measures were again negatively correlated with Ki values,
although not signiﬁcantly (200 lV: Spearman ⍴ = 0.41, P =
0.077; 300 lV: Spearman ⍴ = 0.38, P = 0.099), while corre-
sponding Bayes factors again provided strong evidence in favour
of the null hypothesis H0 (200 lV: BF01 = 10.23; 300 lV:
BF01 = 10.29).
Discussion
Spontaneous EBR has become increasingly popular as a putative
behavioural marker of endogenous dopamine. Interestingly, most of
the past studies that have used sEBR in this capacity have loosely
referred to ‘dopamine function’ or ‘dopamine activity’, perhaps
reﬂecting the current dearth of knowledge regarding which speciﬁc
aspect(s) of the dopamine system correlate(s) with sEBR. Here we
tested the hypothesis of a positive relationship between sEBR and
striatal dopamine synthesis capacity, based on the proposal that
sEBR is positively related to striatal dopamine function (Jongkees &
Colzato, 2016), and previous results showing a positive correlation
between sEBR and striatal dopamine levels measured in post-mor-
tem monkey brains (Taylor et al., 1999). Both frequentist and Baye-
sian statistics, as well as ROI and voxel-wise analyses, argue against
the existence of such a positive relationship in our sample and show
that, if anything, the evidence is in favour of a negative relationship.
While we prefer to refrain from making speculative interpretations
regarding the existence of a negative relationship, given the moder-
ate level of evidence, we believe these data provide a strong cau-
tionary message against the use of sEBR as a positive predictor of
pre-synaptic striatal dopamine.
Importantly, our data speak speciﬁcally to dopamine synthesis
capacity and do not preclude correlations of sEBR with other
aspects of the dopamine system, including (changes in) dopamine
D2 receptor availability. It has been suggested that sEBR might pri-
marily reﬂect striatal D2 receptor activity, based on the observation
of a positive correlation with D2 receptor availability in monkeys
(Groman et al., 2014), and the observation that sEBR better predicts
D2-mediated punishment learning than D1-mediated reward learning
(Cavanagh et al., 2014; Slagter et al., 2015). However, this relation-
ship between sEBR and dopamine D2 functioning has been recently
questioned by a PET study which failed to replicate it in humans
(Dang et al., 2017). Also, such a relationship remains difﬁcult to
reconcile with recent ﬁndings showing a positive association
between dopamine D2 receptor availability and dopamine synthesis
capacity (Berry et al., 2018; but see Ito et al., 2011, showing a neg-
ative association, although in a much smaller sample size of n = 14
instead of n = 40), as this would predict a positive relationship
between sEBR and dopamine synthesis capacity, in contrast to our
results. These inconsistencies certainly call for further research to
better elucidate the dopaminergic mechanisms underlying sEBR.
This study is not devoid of limitations. First, our sample size
(n = 20) is relatively small, although one should note that it is larger
than the samples used in many of the psychopharmacological studies
that have investigated dopaminergic drug effects on sEBR (Jongkees
& Colzato, 2016). In fact, a power analysis performed with GPow-
er3.1 (Faul et al., 2009) suggests that a sample size of 12 individu-
als should have been sufﬁcient to replicate with 95% power the
positive relationship reported by Taylor et al. (1999) between stri-
atal dopamine levels and sEBR in monkeys (original effect size:
R² = 0.62). In addition, as argued by Dang et al. (2017), the use of
Fig. 2. Control and exploratory analyses. (A) Robustness check for the Bayesian correlation analysis. This graph shows that the Bayes factor quantifying the rela-
tive evidence for the absence vs. presence of a positive correlation exceeds the critical threshold of 3 for a large range of beta prior widths, even extending to strong
prior beliefs in the existence of a positive correlation (values < 1 correspond to a prior biased in favour of a positive correlation, values > 1 correspond to a prior
biased in favour of an absence of a positive correlation and value = 1 corresponds to an uninformative (ﬂat) prior as used in our main analysis). (B) Unthresholded
t-map resulting from a voxel-wise analysis investigating the relationship between sEBR and Ki values in an anatomical mask of the striatum. Note that almost all t-
values (including those that do not reach statistical signiﬁcance) are negative, illustrating that the relationship between sEBR and dopamine synthesis capacity is neg-
ative across a large portion of the striatum. This negative relationship shows a signiﬁcant peak in the left nucleus accumbens (x, y, z = 8, 10, 6), surviving a
voxel-wise FWE-corrected threshold of P < 0.05 within the striatal mask. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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sEBR as a reliable predictor of dopamine function implicitly
requires that the positive relationship between these two variables
should be strong and thus observable even in small samples. For
these reasons, we believe that the preliminary evidence reported here
is valuable, even though a replication in a larger sample size is war-
ranted.
Another aspect that may be perceived as a limitation is the use of
a mixed population of healthy participants and pathological gam-
blers. While we acknowledge that pathological gamblers are not typ-
ical individuals and are characterized, among other things, by
elevated striatal dopamine synthesis (van Holst et al., 2017), we
believe that this is not necessarily an issue in the context of the cur-
rent study. Indeed, our goal was to examine whether individual dif-
ferences in sEBR and dopamine synthesis were positively related,
regardless of the origin of these individual differences. If sEBR is to
be used as proxy measure of dopamine levels, it should be insensi-
tive to the underlying causes of individual variations, so that it can
be effectively used in both clinical and non-clinical populations. In
fact, a large portion of the literature that has led to the hypothesis of
a link between sEBR and dopamine function is based on the study
of clinical populations characterized by dopamine dysfunctions.
Finally, one should note that restricting our analyses to healthy indi-
viduals did not affect the results, still showing moderate evidence
against a positive correlation.
To conclude, our study does not support the hypothesis of a posi-
tive relationship between sEBR and striatal dopamine synthesis, and
if anything, provides evidence against it. Even though it is based on
a modest sample size and needs to be replicated in a larger sample
– which we are currently attempting to do, it warrants caution for
future studies that may be tempted to use sEBR as a proxy measure
of striatal dopamine synthesis capacity.
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